Acute Myeloid Leukemia with Bcr-abl1

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-02-17
Clinical Trial Update: Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia [Phase 2]
This Phase 2 clinical trial evaluates low-intensity chemotherapy in combination with ponatinib and blinatumomab for Philadelphia chromosome-…